ArticleAmerican journal of cancer research2022

BCL-2 inhibitor synergizes with PI3Kδ inhibitor and overcomes FLT3 inhibitor resistance in acute myeloid leukaemia.

Ming-Yue Yao et al.PubMed ↗Full text ↗

No numbers read from the abstract.